Comparative evaluation of a new beta-lactamase inhibitor, YTR 830, combined with different beta-lactam antibiotics against bacteria harboring known beta-lactamases
Antibacterial characteristics of YTR 830, a sulfone beta-lactamase inhibitor, compared with those of clavulanic acid and sulbactam
US science education: Will Reagan foot the $830 million bill?
Xeroderma Pigmentosum
Efficacy of 300 mW, 830 nm Laser in the Treatment of Chronic Neck Pain: A Survey in a General Practice Setting
Interpretation of the doublet at 850 and 830 cm-1 in the Raman spectra of tyrosyl residues in proteins and certain model compounds
